Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 160

1.

Sleeping with the hypothalamus: emerging therapeutic targets for sleep disorders.

Mignot E, Taheri S, Nishino S.

Nat Neurosci. 2002 Nov;5 Suppl:1071-5. Review.

PMID:
12403989
2.

The hypocretin/orexin system in health and disease.

Nishino S.

Biol Psychiatry. 2003 Jul 15;54(2):87-95. Review. Erratum in: Biol Psychiatry. 2003 Jul 15;54(2):175.

PMID:
12873797
3.

The sleep-wake cycle, the hypocretin/orexin system and narcolepsy: advances from preclinical research to treatment.

Arias-Carrión O, Bradbury M.

CNS Neurol Disord Drug Targets. 2009 Aug;8(4):232-4.

PMID:
19689304
4.

Hypocretin-1 (orexin A) deficiency in acute traumatic brain injury.

Baumann CR, Stocker R, Imhof HG, Trentz O, Hersberger M, Mignot E, Bassetti CL.

Neurology. 2005 Jul 12;65(1):147-9.

PMID:
16009905
5.

Hypocretin and its emerging role as a target for treatment of sleep disorders.

Cao M, Guilleminault C.

Curr Neurol Neurosci Rep. 2011 Apr;11(2):227-34. doi: 10.1007/s11910-010-0172-9. Review.

PMID:
21170610
6.

The role of the hypothalamic neuropeptides hypocretin/orexin in the sleep-wake cycle.

Salin-Pascual RJ.

Isr Med Assoc J. 2001 Feb;3(2):144-6. Review.

7.

Involvement of hypocretins/orexins in sleep disorders and narcolepsy.

Brown RE.

Drug News Perspect. 2003 Mar;16(2):75-9. Review.

PMID:
12792667
8.

Drugs to interfere with orexins (hypocretins).

Selbach O, Eriksson KS, Haas HL.

Drug News Perspect. 2003 Dec;16(10):669-81. Review.

PMID:
14747847
9.

Neuropeptides as possible targets in sleep disorders: special emphasis on hypocretin-deficient narcolepsy.

Fujiki N, Nishino S.

CNS Neurol Disord Drug Targets. 2007 Feb;6(1):45-62. Review.

PMID:
17305553
10.

The orexin/hypocretin system in zebrafish is connected to the aminergic and cholinergic systems.

Kaslin J, Nystedt JM, Ostergård M, Peitsaro N, Panula P.

J Neurosci. 2004 Mar 17;24(11):2678-89.

11.

Effects of lateral hypothalamic lesion with the neurotoxin hypocretin-2-saporin on sleep in Long-Evans rats.

Gerashchenko D, Blanco-Centurion C, Greco MA, Shiromani PJ.

Neuroscience. 2003;116(1):223-35.

PMID:
12535955
12.

Neuropeptides as possible targets in sleep disorders.

Nishino S, Fujiki N.

Expert Opin Ther Targets. 2007 Jan;11(1):37-59. Review. Erratum in: Expert Opin Ther Targets. 2007 Feb;11(2):263.

PMID:
17150033
14.

[Hypocretin disturbance and sleep disorders].

Billiard M.

Bull Acad Natl Med. 2011 Oct;195(7):1567-78; discussion 1579-81. French.

PMID:
22812161
16.

Alertness and feeding behaviors in ADHD: does the hypocretin/orexin system play a role?

Cortese S, Konofal E, Lecendreux M.

Med Hypotheses. 2008 Nov;71(5):770-5. doi: 10.1016/j.mehy.2008.06.017. Epub 2008 Aug 3.

PMID:
18678446
17.

Narp immunostaining of human hypocretin (orexin) neurons: loss in narcolepsy.

Blouin AM, Thannickal TC, Worley PF, Baraban JM, Reti IM, Siegel JM.

Neurology. 2005 Oct 25;65(8):1189-92. Epub 2005 Aug 31.

PMID:
16135770
18.

Non-sleep effects of hypocretin/orexin.

Samson WK, Taylor MM, Ferguson AV.

Sleep Med Rev. 2005 Aug;9(4):243-52. Epub 2005 Apr 22. Review.

PMID:
16036174
19.
20.

Different neuronal phenotypes in the lateral hypothalamus and their role in sleep and wakefulness.

Gerashchenko D, Shiromani PJ.

Mol Neurobiol. 2004 Feb;29(1):41-59. Review.

PMID:
15034222

Supplemental Content

Support Center